Form 13-F position report

BOSTON SCIENTIFIC CORP

Reported by Legal & General Group Plc

BSX CUSIP 101137107 Manager CIK 0000764068

Reported 11,419,460 shares, up 44,544 (0.4%) from the prior quarter.

Reported value 18.9%; share count 0.4% vs. the prior quarter.

Added
% of reported 13F value 0.23% This manager · Q1 2024
Shares 11,419,460 Quarter-end amount reported
Reported value $782,118,512 Fair value at quarter end
Consecutive quarters held 44 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 445807000
2021-12-31 419527000
2022-03-31 476418000
2022-06-30 416163000
2022-09-30 420049000
2022-12-31 487035563
2023-03-31 538443342
2023-06-30 622301039
2023-09-30 594178428
2023-12-31 657584484
2024-03-31 782118512
2024-06-30 877430842
2024-09-30 933410516
2024-12-31 959190141
2025-03-31 1096372313
2025-06-30 1073378837
2025-09-30 1020934001
2025-12-31 1037085420
2026-03-31 665198075
2026-06-30 431890184

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BOSTON SCIENTIFIC CORP held by Legal & General Group Plc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 10,119,264 -481,502 (-4.5%) 0.09% $431,890,184 2026-08-14
Q1 2026 Reduced 10,600,766 -275,851 (-2.5%) 0.15% $665,198,075 2026-05-08
Q4 2025 Added 10,876,617 +419,442 (4.0%) 0.23% $1,037,085,420 2026-02-09
Q3 2025 Added 10,457,175 +463,889 (4.6%) 0.23% $1,020,934,001 2025-11-13
Q2 2025 Reduced 9,993,286 -874,798 (-8.0%) 0.27% $1,073,378,837 2025-08-12
Q1 2025 Added 10,868,084 +129,278 (1.2%) 0.3% $1,096,372,313 2025-05-15
Q4 2024 Reduced 10,738,806 -399,753 (-3.6%) 0.25% $959,190,141 2025-02-13
Q3 2024 Reduced 11,138,559 -255,140 (-2.2%) 0.25% $933,410,516 2024-11-14
Q2 2024 Reduced 11,393,699 -25,761 (-0.2%) 0.25% $877,430,842 2024-08-14
Q1 2024 Added 11,419,460 +44,544 (0.4%) 0.23% $782,118,512 2024-05-14
Q4 2023 Added 11,374,916 +121,548 (1.1%) 0.2% $657,584,484 2024-02-15
Q3 2023 Reduced 11,253,368 -251,576 (-2.2%) 0.21% $594,178,428 2023-11-14
Q2 2023 Added 11,504,944 +742,518 (6.9%) 0.2% $622,301,039 2023-08-14
Q1 2023 Added 10,762,426 +236,481 (2.2%) 0.19% $538,443,342 2023-05-15
Q4 2022 Reduced 10,525,945 -319,607 (-2.9%) 0.19% $487,035,563 2023-02-14
Q3 2022 Reduced 10,845,552 -320,625 (-2.9%) 0.16% $420,049,000 2022-11-14
Q2 2022 Added 11,166,177 +409,391 (3.8%) 0.15% $416,163,000 2022-08-22
Q1 2022 Added 10,756,786 +880,914 (8.9%) 0.14% $476,418,000 2022-05-16
Q4 2021 Reduced 9,875,872 -398,544 (-3.9%) 0.13% $419,527,000 2022-02-14
Q3 2021 Added 10,274,416 +551,217 (5.7%) 0.14% $445,807,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1296 managers reported BOSTON SCIENTIFIC CORP for Q1 2024.

Managers reporting BOSTON SCIENTIFIC CORP in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 141,930,013 +3,679,063 0.65% $9,720,786,589 44 qtrs
VANGUARD GROUP INC Added 127,437,884 +1,988,082 0.17% $8,728,220,675 44 qtrs
BlackRock Inc Added 126,835,782 +275,950 0.2% $8,686,982,729 44 qtrs
STATE STREET CORPORATION Added 62,728,259 +393,653 0.19% $4,296,258,459 44 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Reduced 46,607,016 -10,568,954 0.95% $3,192,114,525 23 qtrs
PRIMECAP MANAGEMENT CO CA Added 37,947,665 +42,006 1.94% $2,599,035,576 44 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 33,288,817 -3,152,310 0.4% $2,279,951,077 44 qtrs
JPMorgan Chase & Co Added 31,479,634 +2,845,922 0.18% $2,156,040,174 44 qtrs
Bank of America Corporation Added 29,961,685 +1,814,564 0.19% $2,052,075,804 44 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 28,452,663 +896,448 0.18% $1,943,051,820 44 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
9,306,498
Shared
0
None
2,112,962

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.